{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T02:01:41Z","timestamp":1794103301830,"version":"4.8.0"},"reference-count":156,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,20]],"date-time":"2023-12-20T00:00:00Z","timestamp":1703030400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01CA249929"],"award-info":[{"award-number":["R01CA249929"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R37CA259201"],"award-info":[{"award-number":["R37CA259201"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","cmghjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular and Molecular Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2024]]},"DOI":"10.1016\/j.jcmgh.2023.12.010","type":"journal-article","created":{"date-parts":[[2023,12,30]],"date-time":"2023-12-30T04:01:14Z","timestamp":1703908874000},"page":"623-638","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Germline Genetic Associations for Hepatobiliary Cancers"],"prefix":"10.1016","volume":"17","author":[{"given":"Perapa","family":"Chotiprasidhi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela Karina","family":"Sato-Espinoza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6042-6490","authenticated-orcid":false,"given":"Kirk J.","family":"Wangensteen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcmgh.2023.12.010_bib1","first-page":"209","article-title":"Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.jcmgh.2023.12.010_bib2","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1002\/hep.27222","article-title":"Epidemiology of hepatocellular carcinoma in the United States: where are we? where do we go?","volume":"60","author":"El-Serag","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.jcmgh.2023.12.010_bib3","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1002\/cncr.29971","article-title":"Population attributable fractions of risk factors for hepatocellular carcinoma in the United States","volume":"122","author":"Makarova-Rusher","year":"2016","journal-title":"Cancer"},{"key":"10.1016\/j.jcmgh.2023.12.010_bib4","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1002\/hep.24794","article-title":"Family history of liver cancer and hepatocellular carcinoma","volume":"55","author":"Turati","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.jcmgh.2023.12.010_bib5","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.jhep.2008.08.016","article-title":"The association of family history of liver cancer with hepatocellular carcinoma: a case-control study in the United States","volume":"50","author":"Hassan","year":"2009","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jcmgh.2023.12.010_bib6","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1016\/j.cgh.2013.04.043","article-title":"Synergistic effects of family history of hepatocellular carcinoma and hepatitis B virus infection on risk for incident hepatocellular carcinoma","volume":"11","author":"Loomba","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jcmgh.2023.12.010_bib7","first-page":"152","article-title":"PNPLA3 genetic variation in alcoholic steatosis and liver disease progression","volume":"4","author":"Stickel","year":"2015","journal-title":"Hepatobiliary Surg Nutr"},{"issue":"Suppl 1","key":"10.1016\/j.jcmgh.2023.12.010_bib8","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/hep.31481","article-title":"Multiple roles for hepatitis B and C viruses and the host in the development of hepatocellular carcinoma","volume":"73","author":"Wangensteen","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.jcmgh.2023.12.010_bib9","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/s41575-020-0310-z","article-title":"Cholangiocarcinoma 2020: the next horizon in mechanisms and management","volume":"17","author":"Banales","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jcmgh.2023.12.010_bib10","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1097\/01.meg.0000243876.79325.a1","article-title":"Risk factors for extrahepatic biliary tract carcinoma in men: medical conditions and lifestyle\u2014results from a European multicentre case-control study","volume":"19","author":"Ahrens","year":"2007","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.jcmgh.2023.12.010_bib11","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/hep.510270201","article-title":"Risk factors and clinical presentation of hepatobiliary carcinoma in patients with primary sclerosing cholangitis: a case-control study","volume":"27","author":"Bergquist","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.jcmgh.2023.12.010_bib12","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/S0140-6736(05)67530-7","volume":"366","author":"Khan","year":"2005","journal-title":"Cholangiocarcinoma. Lancet"},{"key":"10.1016\/j.jcmgh.2023.12.010_bib13","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1111\/j.1572-0241.1999.01234.x","article-title":"A\u00a0new strategy for the application of CA19-9 in the differentiation of pancreaticobiliary cancer: analysis using a receiver operating characteristic curve","volume":"94","author":"Kim","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jcmgh.2023.12.010_bib14","first-page":"113","article-title":"Bile duct carcinoma: a late complication of congenital hepatic fibrosis\u2014case report and review of literature","volume":"73","author":"Scott","year":"1980","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jcmgh.2023.12.010_bib15","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1053\/j.gastro.2004.12.048","article-title":"Risk factors of intrahepatic cholangiocarcinoma in the United States: a case-control study","volume":"128","author":"Shaib","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jcmgh.2023.12.010_bib16","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1002\/ijc.22283","article-title":"Risk factors for intrahepatic cholangiocarcinoma in a low-risk population: a nationwide case-control study","volume":"120","author":"Welzel","year":"2007","journal-title":"Int J Cancer"},{"issue":"Suppl 1","key":"10.1016\/j.jcmgh.2023.12.010_bib17","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/liv.14086","article-title":"Clinical presentation, diagnosis and staging of cholangiocarcinoma","volume":"39","author":"Forner","year":"2019","journal-title":"Liver Int"},{"key":"10.1016\/j.jcmgh.2023.12.010_bib18","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1056\/NEJMoa021423","article-title":"Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults","volume":"348","author":"Calle","year":"2003","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jcmgh.2023.12.010_bib19","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0140-6736(94)90816-8","article-title":"Cancer mortality in chronic typhoid and paratyphoid carriers","volume":"343","author":"Caygill","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.jcmgh.2023.12.010_bib20","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1038\/sj.bjc.6690101","article-title":"Gallstones, cholecystectomy and risk of cancers of the liver, biliary tract and pancreas","volume":"79","author":"Chow","year":"1999","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jcmgh.2023.12.010_bib21","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1093\/carcin\/23.11.1927","article-title":"Comparative analysis of Helicobacter DNAs and biliary pathology in patients with and without hepatobiliary cancer","volume":"23","author":"Fukuda","year":"2002","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.jcmgh.2023.12.010_bib22","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1111\/j.1572-0241.1999.875_d.x","article-title":"Ultrasonographic evidence of association of polyps and stones with gallbladder cancer","volume":"94","author":"Okamoto","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jcmgh.2023.12.010_bib23","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/ijc.21683","article-title":"Gallbladder cancer worldwide: geographical distribution and risk factors","volume":"118","author":"Randi","year":"2006","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jcmgh.2023.12.010_bib24","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1002\/(SICI)1097-0142(19961001)78:7<1515::AID-CNCR21>3.0.CO;2-1","article-title":"Risk factors for gallbladder cancer: an international collaborative case-control study","volume":"78","author":"Serra","year":"1996","journal-title":"Cancer"},{"key":"10.1016\/j.jcmgh.2023.12.010_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3904\/kjim.1999.14.2.1","article-title":"Choledochal cyst associated the with anomalous union of pancreaticobiliary duct (AUPBD) has a more grave clinical course than choledochal cyst alone","volume":"14","author":"Song","year":"1999","journal-title":"Korean J Intern Med"},{"key":"10.1016\/j.jcmgh.2023.12.010_bib26","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1001\/archsurg.1983.01390080088022","article-title":"Carcinoma in choledochal cysts: age-related incidence","volume":"118","author":"Voyles","year":"1983","journal-title":"Arch Surg"},{"key":"10.1016\/j.jcmgh.2023.12.010_bib27","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1002\/ijc.23159","article-title":"Cigarette smoking, alcohol drinking and the risk of gallbladder cancer death: a prospective cohort study in Japan","volume":"122","author":"Yagyu","year":"2008","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jcmgh.2023.12.010_bib28","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.canlet.2021.09.004","article-title":"Worldwide distribution, associated factors, and trends of gallbladder cancer: a global country-level analysis","volume":"521","author":"Huang","year":"2021","journal-title":"Cancer Lett"},{"key":"10.1016\/j.jcmgh.2023.12.010_bib29","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jhep.2018.03.019","article-title":"Electronic address eee, European Association for the Study of the L. EASL clinical practice guidelines: management of hepatocellular carcinoma","volume":"69","year":"2018","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jcmgh.2023.12.010_bib30","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/hep.29913","article-title":"Diagnosis, staging, and management of hepatocellular carcinoma: 2018 practice guidance by the American Association for the Study of Liver Diseases","volume":"68","author":"Marrero","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.jcmgh.2023.12.010_bib31","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1016\/j.cgh.2019.07.011","article-title":"AGA clinical practice update on surveillance for hepatobiliary cancers in patients with primary sclerosing cholangitis: expert review","volume":"17","author":"Bowlus","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jcmgh.2023.12.010_bib32","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.dld.2015.11.017","article-title":"Cholangiocarcinoma: current opinion on clinical practice diagnostic and therapeutic algorithms\u2014a review of the literature and a long-standing experience of a referral center","volume":"48","author":"Brandi","year":"2016","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.jcmgh.2023.12.010_bib33","first-page":"88","article-title":"Complex segregation analysis of primary hepatocellular carcinoma in Chinese families: interaction of inherited susceptibility and hepatitis B viral infection","volume":"49","author":"Shen","year":"1991","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.jcmgh.2023.12.010_bib34","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1093\/jnci\/92.14.1159","article-title":"Familial risk of hepatocellular carcinoma among chronic hepatitis B carriers and their relatives","volume":"92","author":"Yu","year":"2000","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.jcmgh.2023.12.010_bib35","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1002\/1097-0142(19800401)45:7<1705::AID-CNCR2820450731>3.0.CO;2-S","article-title":"Gallbladder cancer in Hispanic New Mexicans: I\u2014general population, 1957-1977","volume":"45","author":"Devor","year":"1980","journal-title":"Cancer"},{"key":"10.1016\/j.jcmgh.2023.12.010_bib36","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1002\/1097-0142(19820915)50:6<1200::AID-CNCR2820500630>3.0.CO;2-A","article-title":"Adenocarcinoma of the gallbladder in two siblings","volume":"50","author":"Trajber","year":"1982","journal-title":"Cancer"},{"key":"10.1016\/j.jcmgh.2023.12.010_bib37","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14081938","article-title":"Familial risks for liver, gallbladder and bile duct cancers and for their risk factors in Sweden, a low-incidence country","volume":"14","author":"Hemminki","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jcmgh.2023.12.010_bib38","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/gim.2014.147","article-title":"A\u00a0practice guideline from the American College of Medical Genetics and Genomics and the National Society of Genetic Counselors: referral indications for cancer predisposition assessment","volume":"17","author":"Hampel","year":"2015","journal-title":"Genet Med"},{"key":"10.1016\/j.jcmgh.2023.12.010_bib39","doi-asserted-by":"crossref","first-page":"77","DOI":"10.6004\/jnccn.2021.0001","article-title":"Genetic\/familial high-risk assessment: breast, ovarian, and pancreatic, version 2.2021, NCCN clinical practice guidelines in oncology","volume":"19","author":"Daly","year":"2021","journal-title":"J\u00a0Natl Compr Canc Netw"},{"key":"10.1016\/j.jcmgh.2023.12.010_bib40","first-page":"1122","article-title":"NCCN guidelines(R) insights: genetic\/familial high-risk assessment\u2014colorectal, version 1.2021","volume":"19","author":"Weiss","year":"2021","journal-title":"J\u00a0Natl Compr Canc Netw"},{"key":"10.1016\/j.jcmgh.2023.12.010_bib41","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1001\/jamaoncol.2020.6252","article-title":"Comparison of universal genetic testing vs guideline-directed targeted testing for patients with hereditary cancer syndrome","volume":"7","author":"Samadder","year":"2021","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.jcmgh.2023.12.010_bib42","article-title":"Biobanking as a tool for genomic research: from allele frequencies to cross-ancestry association studies","volume":"12","author":"Lazareva","year":"2022","journal-title":"J\u00a0Pers Med"},{"key":"10.1016\/j.jcmgh.2023.12.010_bib43","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jmoldx.2016.10.002","article-title":"Standards and guidelines for the interpretation and reporting of sequence variants in cancer: a joint consensus recommendation of the Association for Molecular Pathology, American Society of Clinical Oncology, and College of American Pathologists","volume":"19","author":"Li","year":"2017","journal-title":"J\u00a0Mol Diagn"},{"key":"10.1016\/j.jcmgh.2023.12.010_bib44","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1038\/s41588-018-0183-z","article-title":"Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations","volume":"50","author":"Khera","year":"2018","journal-title":"Nat Genet"},{"key":"10.1016\/j.jcmgh.2023.12.010_bib45","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/nrg2554","article-title":"Human genetic variation and its contribution to complex traits","volume":"10","author":"Frazer","year":"2009","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.jcmgh.2023.12.010_bib46","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/978-1-62703-514-9_8","article-title":"Exome sequencing analysis: a guide to disease variant detection","volume":"1038","author":"Isakov","year":"2013","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.jcmgh.2023.12.010_bib47","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/aps.2015.89","article-title":"Cancer predisposition genes: molecular mechanisms and clinical impact on personalized cancer care\u2014examples of Lynch and HBOC syndromes","volume":"37","author":"Wang","year":"2016","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.jcmgh.2023.12.010_bib48","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1056\/NEJMoa1706450","article-title":"Olaparib for metastatic breast cancer in patients with a germline BRCA mutation","volume":"377","author":"Robson","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jcmgh.2023.12.010_bib49","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1056\/NEJMoa1802905","article-title":"Talazoparib in patients with advanced breast cancer and a germline BRCA mutation","volume":"379","author":"Litton","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jcmgh.2023.12.010_bib50","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1056\/NEJMoa1506859","article-title":"DNA-repair defects and olaparib in metastatic prostate cancer","volume":"373","author":"Mateo","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jcmgh.2023.12.010_bib51","doi-asserted-by":"crossref","first-page":"8109","DOI":"10.1158\/0008-5472.CAN-06-0140","article-title":"Deficiency in the repair of DNA damage by homologous recombination and sensitivity to poly(ADP-ribose) polymerase inhibition","volume":"66","author":"McCabe","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.jcmgh.2023.12.010_bib52","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1056\/NEJMoa1810858","article-title":"Maintenance olaparib in patients with newly diagnosed advanced ovarian cancer","volume":"379","author":"Moore","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jcmgh.2023.12.010_bib53","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.564601","article-title":"PARP inhibitors: clinical relevance, mechanisms of action and tumor resistance","volume":"8","author":"Rose","year":"2020","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.jcmgh.2023.12.010_bib54","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1038\/ng.2804","article-title":"Evaluating empirical bounds on complex disease genetic architecture","volume":"45","author":"Agarwala","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/j.jcmgh.2023.12.010_bib55","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1038\/s41588-023-01497-6","article-title":"Genome-wide association meta-analysis identifies 17 loci associated with nonalcoholic fatty liver disease","volume":"55","author":"Chen","year":"2023","journal-title":"Nat Genet"},{"key":"10.1016\/j.jcmgh.2023.12.010_bib56","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1038\/s41588-022-01199-5","article-title":"Multiomics study of nonalcoholic fatty liver disease","volume":"54","author":"Sveinbjornsson","year":"2022","journal-title":"Nat Genet"},{"key":"10.1016\/j.jcmgh.2023.12.010_bib57","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/s41588-022-01078-z","article-title":"A\u00a0multiancestry genome-wide association study of unexplained chronic ALT elevation as a proxy for nonalcoholic fatty liver disease with histological and radiological validation","volume":"54","author":"Vujkovic","year":"2022","journal-title":"Nat Genet"},{"key":"10.1016\/j.jcmgh.2023.12.010_bib58","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1053\/j.gastro.2020.12.011","article-title":"Association of genetic variation with cirrhosis: a multi-trait genome-wide association and gene-environment interaction study","volume":"160","author":"Emdin","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jcmgh.2023.12.010_bib59","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jhep.2020.08.027","article-title":"rs641738C>T near MBOAT7 is associated with liver fat, ALT and fibrosis in NAFLD: a meta-analysis","volume":"74","author":"Teo","year":"2021","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jcmgh.2023.12.010_bib155","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1158\/1078-0432.CCR-17-2537","article-title":"Genome-wide association study identifies a new locus at 7q21.13 associated with hepatitis B virus-related hepatocellular carcinoma","volume":"24","author":"Li","year":"2018","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jcmgh.2023.12.010_bib77","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/ng.876","article-title":"Variation in the DEPDC5 locus is associated with progression to hepatocellular carcinoma in chronic hepatitis C virus carriers","volume":"43","author":"Miki","year":"2011","journal-title":"Nat Genet"},{"key":"10.1016\/j.jcmgh.2023.12.010_bib92","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1002791","article-title":"GWAS identifies novel susceptibility loci on 6p21.32 and 21q21.3 for hepatocellular carcinoma in chronic hepatitis B virus carriers","volume":"8","author":"Li","year":"2012","journal-title":"PLoS Genet"},{"key":"10.1016\/j.jcmgh.2023.12.010_bib152","doi-asserted-by":"crossref","first-page":"7958","DOI":"10.1038\/s41598-018-26217-7","article-title":"Genome-wide association study identified new susceptible genetic variants in HLA class I region for hepatitis B virus-related hepatocellular carcinoma","volume":"8","author":"Sawai","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.jcmgh.2023.12.010_bib153","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/ng.2483","article-title":"Genetic variants in STAT4 and HLA-DQ genes confer risk of hepatitis B virus-related hepatocellular carcinoma","volume":"45","author":"Jiang","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/j.jcmgh.2023.12.010_bib80","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/ng.809","article-title":"Genome-wide association study identifies a susceptibility locus for HCV-induced hepatocellular carcinoma","volume":"43","author":"Kumar","year":"2011","journal-title":"Nat Genet"},{"key":"10.1016\/j.jcmgh.2023.12.010_bib154","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1002\/hep.29531","article-title":"Human leukocyte antigen variants and risk of hepatocellular carcinoma modified by hepatitis C virus genotypes: a genome-wide association study","volume":"67","author":"Lee","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.jcmgh.2023.12.010_bib156","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/s41588-020-0640-3","article-title":"Large-scale genome-wide association study in a Japanese population identifies novel susceptibility loci across different diseases","volume":"52","author":"Ishigaki","year":"2020","journal-title":"Nat Genet"},{"key":"10.1016\/j.jcmgh.2023.12.010_bib88","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/ng.638","article-title":"Genome-wide association study identifies 1p36.22 as a new susceptibility locus for hepatocellular carcinoma in chronic hepatitis B virus carriers","volume":"42","author":"Zhang","year":"2010","journal-title":"Nat Genet"},{"key":"10.1016\/j.jcmgh.2023.12.010_bib61","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1136\/gutjnl-2022-327196","article-title":"Genetic variation in TERT modifies the risk of hepatocellular carcinoma in alcohol-related cirrhosis: results from a genome-wide case-control study","volume":"72","author":"Buch","year":"2023","journal-title":"Gut"},{"key":"10.1016\/j.jcmgh.2023.12.010_bib60","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S1470-2045(21)00603-3","article-title":"Common genetic variation in alcohol-related hepatocellular carcinoma: a case-control genome-wide association study","volume":"23","author":"Trepo","year":"2022","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jcmgh.2023.12.010_bib140","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1002\/jgh3.12682","article-title":"Genetic susceptibility to hepatocellular carcinoma in chromosome 22q13.31, findings of a genome-wide association study","volume":"5","author":"Wang","year":"2021","journal-title":"JGH Open"},{"key":"10.1016\/j.jcmgh.2023.12.010_bib75","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0185490","article-title":"Risk estimation model for nonalcoholic fatty liver disease in the Japanese using multiple genetic markers","volume":"13","author":"Kawaguchi","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.jcmgh.2023.12.010_bib84","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1053\/j.gastro.2017.01.041","article-title":"Genome-wide association study identifies TLL1 variant associated with development of hepatocellular carcinoma after eradication of hepatitis C virus infection","volume":"152","author":"Matsuura","year":"2017","journal-title":"Gastroenterology"},{"issue":"Suppl","key":"10.1016\/j.jcmgh.2023.12.010_bib62","doi-asserted-by":"crossref","first-page":"S63","DOI":"10.1194\/jlr.R800082-JLR200","article-title":"Mammalian patatin domain containing proteins: a family with diverse lipolytic activities involved in multiple biological functions","volume":"50","author":"Kienesberger","year":"2009","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.jcmgh.2023.12.010_bib63","doi-asserted-by":"crossref","DOI":"10.3390\/cells9102247","article-title":"Discovery and targeting of the signaling controls of PNPLA3 to effectively reduce transcription, expression, and function in pre-clinical NAFLD\/NASH settings","volume":"9","author":"Schwartz","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.jcmgh.2023.12.010_bib64","doi-asserted-by":"crossref","first-page":"2998","DOI":"10.1002\/hep.32063","article-title":"Modeling PNPLA3-associated NAFLD using human-induced pluripotent stem cells","volume":"74","author":"Tilson","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.jcmgh.2023.12.010_bib65","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1111\/jcmm.14839","article-title":"PNPLA3 I148M mediates the regulatory effect of NF-kB on inflammation in PA-treated HepG2 cells","volume":"24","author":"Yuan","year":"2020","journal-title":"J\u00a0Cell Mol Med"},{"key":"10.1016\/j.jcmgh.2023.12.010_bib66","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/hep.27242","article-title":"Pnpla3I148M knockin mice accumulate PNPLA3 on lipid droplets and develop hepatic steatosis","volume":"61","author":"Smagris","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.jcmgh.2023.12.010_bib67","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.3748\/wjg.v28.i25.2937","article-title":"Mechanism and therapeutic strategy of hepatic TM6SF2-deficient non-alcoholic fatty liver diseases via in\u00a0vivo and in\u00a0vitro experiments","volume":"28","author":"Li","year":"2022","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jcmgh.2023.12.010_bib68","doi-asserted-by":"crossref","first-page":"8913","DOI":"10.1073\/pnas.1323785111","article-title":"TM6SF2 is a regulator of liver fat metabolism influencing triglyceride secretion and hepatic lipid droplet content","volume":"111","author":"Mahdessian","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jcmgh.2023.12.010_bib69","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1002\/hep.31771","article-title":"Liver-specific deletion of mouse Tm6sf2 promotes steatosis, fibrosis, and hepatocellular cancer","volume":"74","author":"Newberry","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.jcmgh.2023.12.010_bib70","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14215468","article-title":"Wnt\/beta-catenin signaling as a driver of stemness and metabolic reprogramming in hepatocellular carcinoma","volume":"14","author":"Leung","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jcmgh.2023.12.010_bib71","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/s13045-020-00990-3","article-title":"Targeting the Wnt\/beta-catenin signaling pathway in cancer","volume":"13","author":"Zhang","year":"2020","journal-title":"J\u00a0Hematol Oncol"},{"key":"10.1016\/j.jcmgh.2023.12.010_bib72","first-page":"7776","article-title":"Associations of TERT polymorphisms with hepatocellular carcinoma risk in a Han Chinese population","volume":"10","author":"Zhang","year":"2017","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1016\/j.jcmgh.2023.12.010_bib73","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1172\/JCI43578","article-title":"Progerin and telomere dysfunction collaborate to trigger cellular senescence in normal human fibroblasts","volume":"121","author":"Cao","year":"2011","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jcmgh.2023.12.010_bib74","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1042\/BC20080205","article-title":"Structure-function relationships in telomerase genes","volume":"101","author":"Sykorova","year":"2009","journal-title":"Biol Cell"},{"key":"10.1016\/j.jcmgh.2023.12.010_bib76","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.1093\/hmg\/ddad099","article-title":"Metabolic liver cancer: associations of rare and common germline variants in one-carbon metabolism and DNA methylation genes","volume":"32","author":"Antwi","year":"2023","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.jcmgh.2023.12.010_bib78","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1186\/s12879-014-0632-y","article-title":"Variations in DEPDC5 gene and its association with chronic hepatitis C virus infection in Saudi Arabia","volume":"14","author":"Al-Anazi","year":"2014","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jcmgh.2023.12.010_bib79","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/hep.28322","article-title":"DEPDC5 variants increase fibrosis progression in Europeans with chronic hepatitis C virus infection","volume":"63","author":"Burza","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.jcmgh.2023.12.010_bib81","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1007\/s12253-019-00738-6","article-title":"Association between MICA rs2596542 polymorphism with the risk of hepatocellular carcinoma in chronic hepatitis C patients","volume":"26","author":"Marangon","year":"2020","journal-title":"Pathol Oncol Res"},{"key":"10.1016\/j.jcmgh.2023.12.010_bib82","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1093\/carcin\/bgu215","article-title":"MICA polymorphism: biology and importance in cancer","volume":"35","author":"Chen","year":"2014","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.jcmgh.2023.12.010_bib83","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s12881-019-0871-2","article-title":"Relationship between the rs2596542 polymorphism in the MICA gene promoter and HBV\/HCV infection-induced hepatocellular carcinoma: a meta-analysis","volume":"20","author":"Luo","year":"2019","journal-title":"BMC Med Genet"},{"key":"10.1016\/j.jcmgh.2023.12.010_bib85","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1111\/jvh.13155","article-title":"TLL1 variants do not predict hepatocellular carcinoma development in HCV cirrhotic patients treated with direct-acting antivirals","volume":"26","author":"Degasperi","year":"2019","journal-title":"J\u00a0Viral Hepat"},{"key":"10.1016\/j.jcmgh.2023.12.010_bib86","doi-asserted-by":"crossref","first-page":"330","DOI":"10.5114\/ceh.2022.122289","article-title":"Tolloid-like 1 gene variant rs17047200, pretreatment FIB-4, ALBI and PALBI scores as predictors of hepatocellular carcinoma occurrence after directly acting antivirals","volume":"8","author":"Kamal","year":"2022","journal-title":"Clin Exp Hepatol"},{"key":"10.1016\/j.jcmgh.2023.12.010_bib87","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/hep4.1466","article-title":"Tolloid-like 1 negatively regulates hepatic differentiation of human induced pluripotent stem cells through transforming growth factor beta signaling","volume":"4","author":"Kiso","year":"2020","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.jcmgh.2023.12.010_bib89","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0045128","article-title":"Role of single nucleotide polymorphisms of KIF1B gene in HBV-associated viral hepatitis","volume":"7","author":"Al-Qahtani","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jcmgh.2023.12.010_bib90","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.7314\/APJCP.2013.14.5.2865","article-title":"The KIF1B (rs17401966) single nucleotide polymorphism is not associated with the development of HBV-related hepatocellular carcinoma in Thai patients","volume":"14","author":"Sopipong","year":"2013","journal-title":"Asian Pac J Cancer Prev"},{"key":"10.1016\/j.jcmgh.2023.12.010_bib91","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.chom.2011.08.010","article-title":"Kinesin-1-mediated capsid disassembly and disruption of the nuclear pore complex promote virus infection","volume":"10","author":"Strunze","year":"2011","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.jcmgh.2023.12.010_bib93","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1159\/000015558","article-title":"Genomic organization, proposed alternative splicing mechanisms, and RNA editing structure of GRIK1","volume":"88","author":"Barbon","year":"2000","journal-title":"Cytogenet Cell Genet"},{"key":"10.1016\/j.jcmgh.2023.12.010_bib94","article-title":"Multigene panel testing in individuals with hepatocellular carcinoma identifies pathogenic germline variants","volume":"5","author":"Mezina","year":"2021","journal-title":"JCO Precis Oncol"},{"key":"10.1016\/j.jcmgh.2023.12.010_bib95","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1158\/1940-6207.CAPR-21-0189","article-title":"Germline cancer susceptibility gene testing in unselected patients with hepatobiliary cancers: a multi-center prospective study","volume":"15","author":"Uson Junior","year":"2022","journal-title":"Cancer Prev Res (Phila)"},{"key":"10.1016\/j.jcmgh.2023.12.010_bib96","doi-asserted-by":"crossref","first-page":"4701","DOI":"10.1158\/1078-0432.CCR-19-0127","article-title":"Alterations in DNA damage repair genes in primary liver cancer","volume":"25","author":"Lin","year":"2019","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jcmgh.2023.12.010_bib97","article-title":"Analysis of mutations in DNA damage repair pathway gene in Chinese patients with hepatocellular carcinoma","volume":"12","author":"Li","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.jcmgh.2023.12.010_bib98","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15010201","article-title":"Low frequency of cancer-predisposition gene mutations in liver transplant candidates with hepatocellular carcinoma","volume":"15","author":"Horackova","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jcmgh.2023.12.010_bib99","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14215278","article-title":"DNA repair mechanisms, protein interactions and therapeutic targeting of the MRN complex","volume":"14","author":"McCarthy-Leo","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jcmgh.2023.12.010_bib100","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/sj.embor.embor925","article-title":"The MRN complex: coordinating and mediating the response to broken chromosomes","volume":"4","author":"van den Bosch","year":"2003","journal-title":"EMBO Rep"},{"key":"10.1016\/j.jcmgh.2023.12.010_bib101","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1002\/hep.32812","article-title":"Clinicogenomic characteristics and synthetic lethal implications of germline homologous recombination-deficient hepatocellular carcinoma","volume":"78","author":"An","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.jcmgh.2023.12.010_bib102","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1248\/bpb.b18-00028","article-title":"Dysregulation of BSEP and MRP2 may play an important role in isoniazid-induced liver injury via the SIRT1\/FXR pathway in rats and HepG2 cells","volume":"41","author":"Qu","year":"2018","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.jcmgh.2023.12.010_bib103","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114109","article-title":"Recent advances in DDR (DNA damage response) inhibitors for cancer therapy","volume":"230","author":"Cheng","year":"2022","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.jcmgh.2023.12.010_bib104","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s12943-021-01315-9","article-title":"PARP inhibitor olaparib overcomes sorafenib resistance through reshaping the pluripotent transcriptome in hepatocellular carcinoma","volume":"20","author":"Yang","year":"2021","journal-title":"Mol Cancer"},{"key":"10.1016\/j.jcmgh.2023.12.010_bib105","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000030719","article-title":"Durable response to olaparib combined low-dose cisplatin in advanced hepatocellular carcinoma with FANCA mutation: a case report","volume":"101","author":"Lai","year":"2022","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jcmgh.2023.12.010_bib106","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1056\/NEJMoa1712191","article-title":"A\u00a0protein-truncating HSD17B13 variant and protection from chronic liver disease","volume":"378","author":"Abul-Husn","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jcmgh.2023.12.010_bib107","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/hep.30623","article-title":"A\u00a017-beta-hydroxysteroid dehydrogenase 13 variant protects from hepatocellular carcinoma development in alcoholic liver disease","volume":"70","author":"Yang","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.jcmgh.2023.12.010_bib108","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/hep.30996","article-title":"Genetic variation in HSD17B13 reduces the risk of developing cirrhosis and hepatocellular carcinoma in alcohol misusers","volume":"72","author":"Stickel","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.jcmgh.2023.12.010_bib109","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/apt.17292","article-title":"Review article: the role of HSD17B13 on global epidemiology, natural history, pathogenesis and treatment of NAFLD","volume":"57","author":"Amangurbanova","year":"2023","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jcmgh.2023.12.010_bib110","doi-asserted-by":"crossref","first-page":"11437","DOI":"10.1073\/pnas.1410741111","article-title":"Comparative proteomic study reveals 17beta-HSD13 as a pathogenic protein in nonalcoholic fatty liver disease","volume":"111","author":"Su","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jcmgh.2023.12.010_bib111","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1056\/NEJMoa2117872","article-title":"Germline mutations in CIDEB and protection against liver disease","volume":"387","author":"Verweij","year":"2022","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jcmgh.2023.12.010_bib112","first-page":"624","article-title":"CIDEB variants protect against liver disease","volume":"19","author":"Kotsiliti","year":"2022","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jcmgh.2023.12.010_bib113","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.bbrc.2013.10.080","article-title":"Human serum activates CIDEB-mediated lipid droplet enlargement in hepatoma cells","volume":"441","author":"Singaravelu","year":"2013","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jcmgh.2023.12.010_bib114","unstructured":"Roberts LR. International Consortium for the Genetics of Biliary Tract Cancers Cholangiocarcinoma Genome Wide Association Study. NIH RePORTER. Updated April 10, 2023. Available at: https:\/\/reporter.nih.gov\/project-details\/10608848. Accessed September 23,\u00a02023."},{"key":"10.1016\/j.jcmgh.2023.12.010_bib115","unstructured":"McGlynn K. Genome wide association study (GWAS) of cholangiocarcinoma (CCA). NIH Cancer Data Access System. Updated June 2, 2023. Available at: https:\/\/cdas.cancer.gov\/approved-projects\/2627\/. Accessed September 23,\u00a02023."},{"key":"10.1016\/j.jcmgh.2023.12.010_bib116","article-title":"Comprehensive germline and somatic genomic profiles of Chinese patients with biliary tract cancer","volume":"12","author":"Yu","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.jcmgh.2023.12.010_bib117","doi-asserted-by":"crossref","DOI":"10.1080\/15384047.2023.2223375","article-title":"Genomic profiling, prognosis, and potential interventional targets in young and old patients with cholangiocarcinoma","volume":"24","author":"Wang","year":"2023","journal-title":"Cancer Biol Ther"},{"key":"10.1016\/j.jcmgh.2023.12.010_bib118","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1002\/cncr.32740","article-title":"Germline alterations in patients with biliary tract cancers: a spectrum of significant and previously underappreciated findings","volume":"126","author":"Maynard","year":"2020","journal-title":"Cancer"},{"key":"10.1016\/j.jcmgh.2023.12.010_bib119","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.jhep.2018.01.009","article-title":"Genomic characterization of biliary tract cancers identifies driver genes and predisposing mutations","volume":"68","author":"Wardell","year":"2018","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jcmgh.2023.12.010_bib120","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.jhep.2022.09.025","article-title":"Hereditary cancer variants and homologous recombination deficiency in biliary tract cancer","volume":"78","author":"Okawa","year":"2023","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jcmgh.2023.12.010_bib121","first-page":"519","article-title":"An update on PARP inhibitors for the treatment of cancer","volume":"8","author":"Benafif","year":"2015","journal-title":"Onco Targets Ther"},{"key":"10.1016\/j.jcmgh.2023.12.010_bib122","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.ejca.2022.05.004","article-title":"Gene mutational profile of BRCAness and clinical implication in predicting response to platinum-based chemotherapy in patients with intrahepatic cholangiocarcinoma","volume":"171","author":"Rimini","year":"2022","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jcmgh.2023.12.010_bib123","unstructured":"Bekaii-Saab TS. Liposomal irinotecan, fluorouracil, leucovorin calcium, and rucaparib in treating patients with metastatic pancreatic, colorectal, gastroesophageal, or biliary cancer. ClinicalTrials.gov. Updated October 13, 2023. Available at: https:\/\/classic.clinicaltrials.gov\/ct2\/show\/NCT03337087?cond=NCT03337087&draw=2&rank=1. Accessed September 5,\u00a02023."},{"key":"10.1016\/j.jcmgh.2023.12.010_bib124","unstructured":"Sahai V. Rucaparib in combination with nivolumab in patients with advanced or metastatic biliary tract cancer following platinum therapy. ClinicalTrials.gov. Updated August 31, 2023. Available at: https:\/\/classic.clinicaltrials.gov\/ct2\/show\/NCT03639935. Accessed September 5,\u00a02023."},{"key":"10.1016\/j.jcmgh.2023.12.010_bib125","unstructured":"Ahn DH. Olaparib in treating patients with metastatic biliary tract cancer with aberrant DNA repair gene mutations. ClinicalTrials.gov. Updated October 13, 2023. Available at: https:\/\/classic.clinicaltrials.gov\/ct2\/show\/NCT04042831. Accessed September 5,\u00a02023."},{"key":"10.1016\/j.jcmgh.2023.12.010_bib126","unstructured":"He AR. Study of pembrolizumab and olaparib in bile duct cancer. ClinicalTrials.gov. Updated April 5, 2023. Available at: https:\/\/classic.clinicaltrials.gov\/ct2\/show\/NCT04306367?cond=NCT04306367&draw=2&rank=1. Accessed September 5,\u00a02023."},{"key":"10.1016\/j.jcmgh.2023.12.010_bib127","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1002\/ijc.32863","article-title":"Gallbladder and extrahepatic bile duct cancers in the Americas: incidence and mortality patterns and trends","volume":"147","author":"Miranda-Filho","year":"2020","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jcmgh.2023.12.010_bib128","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/jhg.2012.9","article-title":"A\u00a0genome-wide association study identifies SNP in DCC is associated with gallbladder cancer in the Japanese population","volume":"57","author":"Cha","year":"2012","journal-title":"J\u00a0Hum Genet"},{"key":"10.1016\/j.jcmgh.2023.12.010_bib129","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1126\/science.2294591","article-title":"Identification of a chromosome 18q gene that is altered in colorectal cancers","volume":"247","author":"Fearon","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.jcmgh.2023.12.010_bib130","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1056\/NEJM198809013190901","article-title":"Genetic alterations during colorectal-tumor development","volume":"319","author":"Vogelstein","year":"1988","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jcmgh.2023.12.010_bib131","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1186\/1471-2407-12-602","article-title":"Epidermal growth factor receptor (EGFR) mutations and expression in squamous cell carcinoma of the esophagus in central Asia","volume":"12","author":"Abedi-Ardekani","year":"2012","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jcmgh.2023.12.010_bib132","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1136\/jcp.51.8.593","article-title":"Loss of heterozygosity and loss of expression of the DCC gene in gastric cancer","volume":"51","author":"Fang","year":"1998","journal-title":"J\u00a0Clin Pathol"},{"key":"10.1016\/j.jcmgh.2023.12.010_bib133","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0925-4439(00)00054-5","article-title":"The 18q21 region in colorectal and pancreatic cancer: independent loss of DCC and DPC4 expression","volume":"1502","author":"Barbera","year":"2000","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jcmgh.2023.12.010_bib134","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S1470-2045(17)30167-5","article-title":"Common genetic variation and risk of gallbladder cancer in India: a case-control genome-wide association study","volume":"18","author":"Mhatre","year":"2017","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jcmgh.2023.12.010_bib135","doi-asserted-by":"crossref","first-page":"6899","DOI":"10.1038\/srep06899","article-title":"ABCB4 is frequently epigenetically silenced in human cancers and inhibits tumor growth","volume":"4","author":"Kiehl","year":"2014","journal-title":"Sci Rep"},{"key":"10.1016\/j.jcmgh.2023.12.010_bib136","article-title":"Genetics of ABCB1 in cancer","volume":"15","author":"Skinner","year":"2023","journal-title":"Cancer"},{"key":"10.1016\/j.jcmgh.2023.12.010_bib137","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1038\/s41598-018-35852-z","article-title":"Variants in ABCG8 and TRAF3 genes confer risk for gallstone disease in admixed Latinos with Mapuche Native American ancestry","volume":"9","author":"Bustos","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.jcmgh.2023.12.010_bib138","doi-asserted-by":"crossref","first-page":"4585","DOI":"10.7150\/thno.56539","article-title":"Mutational spectrum and precision oncology for biliary tract carcinoma","volume":"11","author":"Lin","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.jcmgh.2023.12.010_bib139","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1093\/jnci\/91.15.1310","article-title":"Cancer risks in BRCA2 mutation carriers","volume":"91","author":"Breast Cancer Linkage","year":"1999","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.jcmgh.2023.12.010_bib141","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.jhep.2020.11.024","article-title":"Non-invasive stratification of hepatocellular carcinoma risk in non-alcoholic fatty liver using polygenic risk scores","volume":"74","author":"Bianco","year":"2021","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jcmgh.2023.12.010_bib142","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.jhep.2022.11.003","article-title":"Integrating genetic variants into clinical models for hepatocellular carcinoma risk stratification in cirrhosis","volume":"78","author":"Nahon","year":"2023","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jcmgh.2023.12.010_bib143","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1002\/hep4.1976","article-title":"NAFLD polygenic risk score and risk of hepatocellular carcinoma in an East Asian population","volume":"6","author":"Thomas","year":"2022","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.jcmgh.2023.12.010_bib144","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0282309","article-title":"Risk stratification for hepatocellular cancer among patients with cirrhosis using a hepatic fat polygenic risk score","volume":"18","author":"Thrift","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.jcmgh.2023.12.010_bib145","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/s41588-019-0379-x","article-title":"Clinical use of current polygenic risk scores may exacerbate health disparities","volume":"51","author":"Martin","year":"2019","journal-title":"Nat Genet"},{"key":"10.1016\/j.jcmgh.2023.12.010_bib146","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/s41591-021-01672-4","article-title":"A\u00a0roadmap to increase diversity in genomic studies","volume":"28","author":"Fatumo","year":"2022","journal-title":"Nat Med"},{"key":"10.1016\/j.jcmgh.2023.12.010_bib147","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/s41576-020-00306-8","article-title":"African genetic diversity and adaptation inform a precision medicine agenda","volume":"22","author":"Pereira","year":"2021","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.jcmgh.2023.12.010_bib148","article-title":"A\u00a0review of cancer genetics and genomics studies in Africa","volume":"10","author":"Rotimi","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.jcmgh.2023.12.010_bib149","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"key":"10.1016\/j.jcmgh.2023.12.010_bib150","article-title":"Liver transplantation for intrahepatic cholangiocarcinoma: a propensity score-matched analysis","volume":"13","author":"Huang","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.jcmgh.2023.12.010_bib151","first-page":"726","article-title":"Hepatic transplantation for primary and metastatic cancers of the liver","volume":"110","author":"Penn","year":"1991","journal-title":"Surgery"}],"container-title":["Cellular and Molecular Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352345X23002266?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352345X23002266?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T18:35:49Z","timestamp":1762454149000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352345X23002266"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":156,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024]]}},"alternative-id":["S2352345X23002266"],"URL":"https:\/\/doi.org\/10.1016\/j.jcmgh.2023.12.010","relation":{},"ISSN":["2352-345X"],"issn-type":[{"value":"2352-345X","type":"print"}],"subject":[],"published":{"date-parts":[[2024]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Germline Genetic Associations for Hepatobiliary Cancers","name":"articletitle","label":"Article Title"},{"value":"Cellular and Molecular Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcmgh.2023.12.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc. on behalf of the AGA Institute.","name":"copyright","label":"Copyright"}]}}